Particle Beam Therapy for Intrahepatic and Extrahepatic Biliary Duct Carcinoma: A Multi-Institutional Retrospective Data Analysis

SIMPLE SUMMARY: We examined the outcome of patients with biliary duct carcinoma treated with particle beam therapy, which has a potential advantage to be prescribed at a higher dose. The median survival time (MST) was 21 months in the total population, and were 20 and 23 months for extrahepatic BDC...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamazaki, Hideya, Kimoto, Takuya, Suzuki, Motohisa, Murakami, Masao, Suzuki, Osamu, Takagi, Masaru, Katoh, Norio, Arimura, Takeshi, Ogino, Takashi, Ogino, Hiroyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736951/
https://www.ncbi.nlm.nih.gov/pubmed/36497346
http://dx.doi.org/10.3390/cancers14235864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9736951/
https://www.ncbi.nlm.nih.gov/pubmed/36497346
http://dx.doi.org/10.3390/cancers14235864

Ejemplares similares